These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21144983)

  • 21. Antimicrobial resistance: consideration as an adverse drug event.
    Martin SJ; Micek ST; Wood GC
    Crit Care Med; 2010 Jun; 38(6 Suppl):S155-61. PubMed ID: 20502169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of resistance: a goal for dose selection for antimicrobial agents.
    Drusano GL
    Clin Infect Dis; 2003 Jan; 36(Suppl 1):S42-50. PubMed ID: 12516029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adverse effects and safety of antimicrobial agents--drug interactions].
    Sawada Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():609-14. PubMed ID: 17455690
    [No Abstract]   [Full Text] [Related]  

  • 24. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.
    Vandijck DM; Depaemelaere M; Labeau SO; Depuydt PO; Annemans L; Buyle FM; Oeyen S; Colpaert KE; Peleman RP; Blot SI; Decruyenaere JM
    Int J Antimicrob Agents; 2008 Feb; 31(2):161-5. PubMed ID: 18164599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of antimicrobial agents and rationale for their dosing.
    MacGowan AP; Bowker KE
    J Chemother; 1997 May; 9 Suppl 1():64-73. PubMed ID: 9248964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of antimicrobials.
    Drusano GL
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S89-95. PubMed ID: 17582578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.
    Lynch JP
    Semin Respir Infect; 1993 Dec; 8(4):268-84. PubMed ID: 7938924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic de-escalation.
    Masterton RG
    Crit Care Clin; 2011 Jan; 27(1):149-62. PubMed ID: 21144991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with levofloxacin in the treatment of pneumonia in ICU patients.
    Alvarez Lerma F;
    J Chemother; 2004 Apr; 16 Suppl 2():15-7. PubMed ID: 15255557
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection.
    Bradley JS; Garonzik SM; Forrest A; Bhavnani SM
    Pediatr Infect Dis J; 2010 Nov; 29(11):1043-6. PubMed ID: 20975453
    [No Abstract]   [Full Text] [Related]  

  • 33. General principles of antimicrobial therapy.
    Thompson RL; Wright AJ
    Mayo Clin Proc; 1998 Oct; 73(10):995-1006. PubMed ID: 9787752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones.
    Wispelwey B
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S127-35. PubMed ID: 15942879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of systemic antibacterial agents at a university emergency clinic in Bucharest, in the year 2008].
    Ion-Nedelcu N; Radu L; Firulescu S; Truţă E; Sîrbu M; Barbu G; Calistru P
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(1):53-8. PubMed ID: 20524396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem.
    Kuti JL; Dandekar PK; Nightingale CH; Nicolau DP
    J Clin Pharmacol; 2003 Oct; 43(10):1116-23. PubMed ID: 14517194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options in an era of decreasing antimicrobial susceptibility.
    Drlica K; Schmitz FJ
    J Chemother; 2002 Feb; 14 Suppl 2():5-12. PubMed ID: 12003139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efforts of pharmacy to reduce antibiotic resistance.
    Klem C; Dasta JF
    New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial drug interactions in the critically ill patients.
    Pereira JM; Paiva JA
    Curr Clin Pharmacol; 2013 Feb; 8(1):25-38. PubMed ID: 22946870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.